Not applicableStudy completedNCT02717364What this trial is testingYervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 556
Early research (Phase 1)Study completedNCT01738139What this trial is testingIpilimumab and Imatinib Mesylate in Advanced CancerWho this might be right forAdvanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more M.D. Anderson Cancer Center 68
Large-scale testing (Phase 3)UnknownNCT00052130What this trial is testingVaccine Therapy for Patients With Stage III MelanomaWho this might be right forMalignant Melanoma CancerVax Corporation 1,118
Testing effectiveness (Phase 2)Study completedNCT00327600What this trial is testingSafety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant MelanomaWho this might be right forMalignant Melanoma AmpliMed Corporation 68
Early research (Phase 1)Ended earlyNCT03420963What this trial is testingDonor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsWho this might be right forRecurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more M.D. Anderson Cancer Center 12
Not applicableActive Not RecruitingNCT03165487What this trial is testingComparison of the Breast Tumor MicroenvironmentWho this might be right forTriple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast Columbia University 14
Early research (Phase 1)Study completedNCT02565758What this trial is testingABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsUndifferentiated Pleomorphic SarcomaSquamous Cell Carcinoma of the Head and Neck+1 more AbbVie 85
Not applicableStudy completedNCT00203008What this trial is testingA Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of MelanomaWho this might be right forParkinson's DiseaseMalignant Melanoma Teva Branded Pharmaceutical Products R&D, Inc. 2,106
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Not applicableStudy completedNCT06657638What this trial is testingCytological Examination of Malignant Pleural Effusion in Breast CancerWho this might be right forMalignant Pleural Effusion Mansoura University Hospital 50
Not applicableStudy completedNCT01433302What this trial is testingInflammatory Response and Tissue Fibrosis/ Lymphatico-venous BypassWho this might be right forBreast CancerGenitourinary CancerMalignant Female Reproductive System Neoplasm+2 more M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT02459067What this trial is testingImmuniCell® in Patients With Advanced CancersWho this might be right forMalignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer TC Biopharm 8
Not applicableActive Not RecruitingNCT02221700What this trial is testingMassage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesWho this might be right forMalignant Breast NeoplasmMalignant Digestive System NeoplasmPeripheral Neuropathy M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)UnknownNCT01565837What this trial is testingConcurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable MelanomaWho this might be right forMelanoma Wolfram Samlowski 50
Not applicableUnknownNCT02938728What this trial is testingDefinition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced MelanomaWho this might be right forMalignant Melanoma Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)WithdrawnNCT03448666What this trial is testingECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral MetastasesWho this might be right forMalignant Melanoma European Institute of Oncology
Not applicableStudy completedNCT03409419What this trial is testingPET Imaging of the Immune System Using Analog ProbesWho this might be right forMalignant Melanoma Jonsson Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT06505577What this trial is testingPreoperative vs. Pathologic Size in Breast Cancer: A Prospective StudyWho this might be right forMastectomyBreast Neoplasm Malignant Primary Incheon St.Mary's Hospital 600
Large-scale testing (Phase 3)Study completedNCT00002892What this trial is testingInterferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent MelanomaWho this might be right forMelanoma (Skin) Institute of Cancer Research, United Kingdom 1,000
Not applicableStudy completedNCT04217382What this trial is testingPre Transplantation MelanomaWho this might be right forMalignant Melanoma Hospices Civils de Lyon 37